Compounds of the formula I:
or pharmaceutically acceptable salts thereof,
wherein A, X, R
1
, R
2
, R
3
and R
4
are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
化合物I的公式或其药学上可接受的盐,其中A、X、R1、R2、R3和R4的定义如本文所述。还揭示了制备该化合物的方法,并将其用于治疗与LRRK2受体相关的疾病,如帕
金森病。